Cronos Group Inc. (CRON), a leading cannabis company, saw its stock soar 5.41% in pre-market trading on Thursday, following the release of its fourth-quarter and full-year 2024 financial results.
The company reported strong revenue growth, with Q4 2024 net revenue increasing by 27% year-over-year to $30.3 million, driven by higher cannabis flower and extract sales in the Canadian market and overseas markets like Israel. For the full year 2024, net revenue surged 35% to $117.6 million, fueled by the same factors.
Cronos Group's flagship brand, Spinach®, solidified its position as the number one cannabis brand in Canada, while its PEACE NATURALS® brand emerged as the market leader in Israel. The company's strategic focus on innovation, product quality, and cost discipline enabled it to achieve robust gross margins of 36% in Q4 and 21% for the full year, significant improvements over the prior year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.